Highlights Aprogen Medicines Inc.

Equities

A007460

KR7007460009

End-of-day quote Korea S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
1,383 ^KRW	+15.83%		+16.51%	+44.06%

05-14	Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-19	Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-19	CI
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Aprogen Medicines Inc. completed the acquisition of remaining unknown stake in Aprogen, Inc.	17/07/22	CI
Aprogen Medicines Inc. signed a merger contract to acquire remaining unknown stake in Aprogen, Inc.	17/11/21	CI
Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..	13/01/21	CI
Aprogen KIC Inc. cancelled the acquisition of remaining stake minority in Aprogen, Inc.	07/09/20	CI
Aprogen KIC Inc. cancelled the acquisition of Aprogen Healthcare & Games Inc..	07/09/20	CI
Aprogen KIC Inc. agreed to acquire Aprogen Healthcare & Games Inc. for approximately KRW 140 billion.	23/04/20	CI
Aprogen KIC Inc. signed a merger agreement to acquire remaining stake minority in Aprogen, Inc.	23/04/20	CI
Aprogen KIC Inc. agreed to acquire additional 5.6% stake in Aprogen pharmaceuticals,Inc. for KRW 17.8 billion.	13/01/20	CI
Aprogen KIC Inc. cancelled the acquisition of additional 2.8% in Aprogen, Inc.	01/11/19	CI
Aprogen Kic Inc cancelled the acquisition of 49.37% stake in Aprogen Biologics Inc from Aprogen pharmaceuticals,Inc. and Aprogen, Inc.	11/06/19	CI
Aprogen KIC Inc. agreed to acquire additional 2.8% in Aprogen, Inc. for KRW 14 billion.	01/11/18	CI
Aprogen Kic Inc agreed to acquire 49.37% stake in Aprogen Biologics Inc from Aprogen pharmaceuticals,Inc. and Aprogen, Inc. for approximately KRW 120 billion.	11/06/18	CI
Genesis Fund 1, Genesis Fund 2, Genesis Fund 3, Blossom Fund 1, Blossom Fund 2, Growth & Value Fund 3, and WJ Consortium completed the acquisition of 45.5% stake in Nara KIC Inc. from Nara Ace Holdings Co., Ltd.	17/12/17	CI
Genesis Fund 1, Genesis Fund 2, Genesis Fund 3, Blossom Fund 1, Blossom Fund 2, Growth & Value Fund 3, and WJ Consortium signed definitive agreement to acquire 45.5% stake in Nara KIC Inc. from Nara Ace Holdings Co., Ltd. for KRW 50 billion.	09/11/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aprogen Medicines Inc.

Equities

A007460

KR7007460009

Highlights

Filters